Recall of Immunoquick HIV Reagent

According to L’Agence nationale de sécurité du médicament et des produits de santé (ANSM), this recall involved a device in France that was produced by Biosynex SA.

What is this?

A correction or removal action taken by a manufacturer to address a problem with a medical device. Recalls occur when a medical device is defective, when it could be a risk to health, or when it is both defective and a risk to health.

Learn more about the data here
  • Type of Event
    Recall
  • Event ID
    R1603451
  • Date
    2016-06-17
  • Event Country
  • Event Source
    ANSM
  • Event Source URL
  • Notes / Alerts
    French data is current through early September 2018. All of the data comes from L’Agence nationale de sécurité du médicament et des produits de santé (ANSM), except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and France.
  • Extra notes in the data
  • Action
    Following the product recall initiated by the company Biosynex, following an injection of it by the ANSM, the distributor Fumouze informed the users of the rapid test Immunoquick HIV withdrawal of this product. The users concerned received the attached mail (17/06/2016) (216 KB). This safety action is registered with the ANSM under the number R1603451. Read auss. Quick Tests - Biosynex SA - Product Recall. (6/16/2016)

Device

  • Model / Serial
  • Product Description
    in-vitro_medical_device
  • Manufacturer

Manufacturer

  • Manufacturer Parent Company (2017)
  • Source
    LAANSM